Metraipolis › archive › dc_ee5ccca5e1b9
From Analytics to Tumor Boards: An Evidence-Linked Multi-Agent Workflow for Oncology Feature Extraction — arXiv:2608.28974
- Source
- arXiv (en)
- Original
- https://arxiv.org/abs/2608.28974
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-17T07:43:55.858Z
- SHA-256 of the archived text
e065489d13e6210aa885c0a66f40bffd72caf156ae64b0c17e13cb8cea9cb9d6- Stable URL of this page
https://metraipolis.com/documento/dc_ee5ccca5e1b9
How to cite
From Analytics to Tumor Boards: An Evidence-Linked Multi-Agent Workflow for Oncology Feature Extraction — arXiv:2608.28974 — arXiv (en), https://arxiv.org/abs/2608.28974 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ee5ccca5e1b9 (Metraipolis archive dc_ee5ccca5e1b9, sha256 e065489d13e6210aa885c0a66f40bffd72caf156ae64b0c17e13cb8cea9cb9d6)
BibTeX
@misc{dcee5ccca5e1b9,
title = {From Analytics to Tumor Boards: An Evidence-Linked Multi-Agent Workflow for Oncology Feature Extraction — arXiv:2608.28974},
howpublished = {arXiv (en)},
url = {https://arxiv.org/abs/2608.28974},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ee5ccca5e1b9; sha256 e065489d13e6210aa885c0a66f40bffd72caf156ae64b0c17e13cb8cea9cb9d6},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.28974. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Clinically relevant oncology information is distributed across heterogeneous, longitudinal documentation, creating substantial abstraction burden and requiring accurate attribution across specimens, tumors, biomarkers, and time points, while manual cancer-registry abstraction can require 27.2 minutes per case, highlighting the need for scalable methods that preserve clinical context while converting documentation into structured data. We evaluate an oncology information-extraction workflow in which OncoLens supplies multi-source, oncology-aware document selection, aggregation, and normalization from integrated EHRs, while the NimbleMind Multi-Agent System (nMAS) is a configurable oncology information-extraction workflow that extracts clinically relevant structured fields from fragmented oncology documentation. The extraction task uses a clinician-informed schema of 328 attributes spanning report metadata, diagnosis, staging, and cancer-type-specific information. nMAS separates clinician-defined field specifications from model execution and combines complexity-aware extraction, report-level consolidation, and source-grounded validation. The retrospective evaluation included 230 de-identified oncology documents from 40 patients and 418 clinician-reviewed document-field pairs containing 1,126 non-empty reference values. Evaluation focused on fields identified by clinicians as present in the source documents rather than exhaustively annotating all 328 schema fields. nMAS achieved a rank-weighted value-level precision of 82.6%, recall of 87.5%, and F1 of 85.0%, compared with an F1 of 66.4% for an independently implemented UMA-style MiniMax M2.5 comparator. These findings support the feasibility of using a configurable, source-grounded extraction workflow to convert fragmented oncology documentation into reusable structured data. Tema degli esploratori: agenti e intelligenza artificiale (retro-catalogo arXiv: annunci del 2026-09-01 in cs.AI). Categorie arXiv: Artificial Intelligence (cs.AI). Pagina del lavoro: https://arxiv.org/abs/2608.28974 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina. Letto il 2026-10-17T07:28:26.492Z dalla pagina https://arxiv.org/catchup/cs.AI/2026-09-01?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).